Literature DB >> 3821485

Staphylococcus aureus meningitis: a broad-based epidemiologic study.

L S Schlesinger, S C Ross, D R Schaberg.   

Abstract

In an effort to ascertain important epidemiologic and prognostic risk factors, we analyzed 33 cases of Staphylococcus aureus meningitis occurring over an 8-year period (1976 to 1984). Staphylococcus aureus caused 6% of all bacterial meningitis at our University Hospital. Fifty percent of cases were pediatric and included 7 newborn infants, of whom 71% were either premature or had low birth weight. Major underlying diseases were: central nervous system (CNS) disorders (55%), endocarditis (21%, predominantly intravenous drug abusers), other sites of infection (27%), and prematurity (24%). Fifty-seven percent of patients were bacteremic and 41% of those had concomitant bacteriuria. Hypoglycorrhachia was present in 27% of cases, positive cerebrospinal fluid (CSF) Gram stain in 20%, disseminated intravascular coagulation (DIC) in 19%, and methicillin-resistant organisms in 18%. Cerebrospinal fluid cultures remained positive for a protracted period (mean, 6.7 days) regardless of the presence or absence of a CNS shunt. Overall mortality was 21%. Favorable outcomes were associated with the eventual presence of sterile CSF (15.4% vs. 100% mortality) and the removal of foreign bodies (10% vs. 67% mortality). Mortality was also associated (p less than 0.5) with the presence of diabetes mellitus, age greater than 60, obtundation or coma on presentation, bacteremia, or DIC. Cure correlated (p less than .05) with CNS shunt-associated infections, age less than 1, normal neurologic examinations on presentation, or the absence of DIC or bacteremia.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3821485     DOI: 10.1097/00005792-198703000-00006

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  10 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.

Authors:  Armin Stucki; Peter Gerber; Fernando Acosta; Marianne Cottagnoud; Philippe Cottagnoud
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

Review 3.  Management of cerebral infection.

Authors:  M Anderson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-12       Impact factor: 10.154

Review 4.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

5.  A case of spontaneous methicillin-resistant Staphylococcus aureus meningitis in a health care worker.

Authors:  Joe Dylewski; Guillaume Martel
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

6.  Bacterial meningitis: epidemiology, pathogenesis and management update.

Authors:  Yuliya Nudelman; Allan R Tunkel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 7.  Bacterial meningitis. Practical guidelines for management.

Authors:  J Rockowitz; A R Tunkel
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

Review 8.  Severe acute myocardial infarction during a staphylococcal septicemia with meningoencephalitis. A possible contraindication to thrombolytic treatment.

Authors:  C A Reynard; P Calain; G P Pizzolato; J C Chevrolet
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

9.  Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases.

Authors:  Michael Pedersen; Thomas L Benfield; Peter Skinhoej; Allan G Jensen
Journal:  BMC Infect Dis       Date:  2006-03-16       Impact factor: 3.090

10.  Methicillin resistant Staphylococcus aureus meningitis.

Authors:  Noella Maria Delia Pereira; Ira Shah; Alpana Ohri; Forum Shah
Journal:  Oxf Med Case Reports       Date:  2015-11-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.